BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37096575)

  • 1. Early Detection of Prostate Cancer: AUA/SUO Guideline Part II: Considerations for a Prostate Biopsy.
    Wei JT; Barocas D; Carlsson S; Coakley F; Eggener S; Etzioni R; Fine SW; Han M; Kim SK; Kirkby E; Konety BR; Miner M; Moses K; Nissenberg MG; Pinto PA; Salami SS; Souter L; Thompson IM; Lin DW
    J Urol; 2023 Jul; 210(1):54-63. PubMed ID: 37096575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening.
    Wei JT; Barocas D; Carlsson S; Coakley F; Eggener S; Etzioni R; Fine SW; Han M; Kim SK; Kirkby E; Konety BR; Miner M; Moses K; Nissenberg MG; Pinto PA; Salami SS; Souter L; Thompson IM; Lin DW
    J Urol; 2023 Jul; 210(1):46-53. PubMed ID: 37096582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part I: Introduction and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence after Radical Prostatectomy.
    Morgan TM; Boorjian SA; Buyyounouski MK; Chapin BF; Chen DYT; Cheng HH; Chou R; Jacene HA; Kamran SC; Kim SK; Kirkby E; Luckenbaugh AN; Nathanson BJ; Nyame YA; Posadas EM; Tran PT; Chen RC
    J Urol; 2024 Apr; 211(4):509-517. PubMed ID: 38421253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy.
    Morgan TM; Boorjian SA; Buyyounouski MK; Chapin BF; Chen DYT; Cheng HH; Chou R; Jacene HA; Kamran SC; Kim SK; Kirkby E; Luckenbaugh AN; Nathanson BJ; Nyame YA; Posadas EM; Tran PT; Chen RC
    J Urol; 2024 Apr; 211(4):518-525. PubMed ID: 38421243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR.
    Rosenkrantz AB; Verma S; Choyke P; Eberhardt SC; Eggener SE; Gaitonde K; Haider MA; Margolis DJ; Marks LS; Pinto P; Sonn GA; Taneja SS
    J Urol; 2016 Dec; 196(6):1613-1618. PubMed ID: 27320841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part III: Salvage Therapy After Radiotherapy or Focal Therapy, Pelvic Nodal Recurrence and Oligometastasis, and Future Directions.
    Morgan TM; Boorjian SA; Buyyounouski MK; Chapin BF; Chen DYT; Cheng HH; Chou R; Jacene HA; Kamran SC; Kim SK; Kirkby E; Luckenbaugh AN; Nathanson BJ; Nyame YA; Posadas EM; Tran PT; Chen RC
    J Urol; 2024 Apr; 211(4):526-532. PubMed ID: 38421252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I.
    Lowrance WT; Breau RH; Chou R; Chapin BF; Crispino T; Dreicer R; Jarrard DF; Kibel AS; Morgan TM; Morgans AK; Oh WK; Resnick MJ; Zietman AL; Cookson MS
    J Urol; 2021 Jan; 205(1):14-21. PubMed ID: 32960679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management.
    Eastham JA; Auffenberg GB; Barocas DA; Chou R; Crispino T; Davis JW; Eggener S; Horwitz EM; Kane CJ; Kirkby E; Lin DW; McBride SM; Morgans AK; Pierorazio PM; Rodrigues G; Wong WW; Boorjian SA
    J Urol; 2022 Jul; 208(1):10-18. PubMed ID: 35536144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline. Part III: Principles of Radiation and Future Directions.
    Eastham JA; Auffenberg GB; Barocas DA; Chou R; Crispino T; Davis JW; Eggener S; Horwitz EM; Kane CJ; Kirkby E; Lin DW; McBride SM; Morgans AK; Pierorazio PM; Rodrigues G; Wong WW; Boorjian SA
    J Urol; 2022 Jul; 208(1):26-33. PubMed ID: 35536141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic and MRI-Cognitive Targeted Transperineal Prostate Biopsy Accuracy in Detecting Clinically Significant Prostate Cancer after Previous Negative Biopsy and Persisting Suspicion of Malignancy.
    Vėželis A; Platkevičius G; Kinčius M; Gumbys L; Naruševičiūtė I; Briedienė R; Petroška D; Ulys A; Jankevičius F
    Medicina (Kaunas); 2021 Jan; 57(1):. PubMed ID: 33435132
    [No Abstract]   [Full Text] [Related]  

  • 11. Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II.
    Lowrance WT; Breau RH; Chou R; Chapin BF; Crispino T; Dreicer R; Jarrard DF; Kibel AS; Morgan TM; Morgans AK; Oh WK; Resnick MJ; Zietman AL; Cookson MS
    J Urol; 2021 Jan; 205(1):22-29. PubMed ID: 32960678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up.
    Eastham JA; Auffenberg GB; Barocas DA; Chou R; Crispino T; Davis JW; Eggener S; Horwitz EM; Kane CJ; Kirkby E; Lin DW; McBride SM; Morgans AK; Pierorazio PM; Rodrigues G; Wong WW; Boorjian SA
    J Urol; 2022 Jul; 208(1):19-25. PubMed ID: 35536148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial experience of magnetic resonance imaging/ultrasonography fusion transperineal biopsy: Biopsy techniques and results for 75 patients.
    Tae JH; Shim JS; Jin HJ; Yoon SG; No TI; Kim JY; Kang SH; Cheon J; Kang SG
    Investig Clin Urol; 2018 Nov; 59(6):363-370. PubMed ID: 30402568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer: A Phase 3 Randomized Clinical Trial.
    Klotz L; Chin J; Black PC; Finelli A; Anidjar M; Bladou F; Mercado A; Levental M; Ghai S; Chang SD; Milot L; Patel C; Kassam Z; Moore C; Kasivisvanathan V; Loblaw A; Kebabdjian M; Earle CC; Pond GR; Haider MA
    JAMA Oncol; 2021 Apr; 7(4):534-542. PubMed ID: 33538782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.
    Nordström T; Discacciati A; Bergman M; Clements M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Eklund M; Grönberg H;
    Lancet Oncol; 2021 Sep; 22(9):1240-1249. PubMed ID: 34391509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Single Center Evaluation of the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging against Transperineal Prostate Mapping Biopsy: An Analysis of Men with Benign Histology and Insignificant Cancer following Transrectal Ultrasound Biopsy.
    Pal RP; Ahmad R; Trecartan S; Voss J; Ahmed S; Bazo A; Lloyd J; Walton TJ
    J Urol; 2018 Aug; 200(2):302-308. PubMed ID: 29477717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is targeted magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy enough for the detection of prostate cancer in patients with PI-RADS ≥3: Results of a prospective, randomized clinical trial.
    Zhang J; Zhu A; Sun D; Guo S; Zhang H; Liu S; Fu Q; Zhang K
    J Cancer Res Ther; 2020; 16(7):1698-1702. PubMed ID: 33565519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Multicenter Study of the Clinical Utility of Nontargeted Systematic Transperineal Prostate Biopsies in Patients Undergoing Pre-Biopsy Multiparametric Magnetic Resonance Imaging.
    Connor MJ; Eldred-Evans D; van Son M; Hosking-Jervis F; Bertoncelli Tanaka M; Reddy D; Bass EJ; Powell L; Ahmad S; Pegers E; Joshi S; Sri D; Wong K; Tam H; Hrouda D; Qazi H; Gordon S; Winkler M; Ahmed HU
    J Urol; 2020 Dec; 204(6):1195-1201. PubMed ID: 32516029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Many Targeted Biopsy Cores are Needed for Clinically Significant Prostate Cancer Detection during Transperineal Magnetic Resonance Imaging Ultrasound Fusion Biopsy?
    Song G; Ruan M; Wang H; Fan Y; He Q; Lin Z; Li X; Li P; Wang X; He Z; Zhou L
    J Urol; 2020 Dec; 204(6):1202-1208. PubMed ID: 32716686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance.
    Radtke JP; Kuru TH; Boxler S; Alt CD; Popeneciu IV; Huettenbrink C; Klein T; Steinemann S; Bergstraesser C; Roethke M; Roth W; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2015 Jan; 193(1):87-94. PubMed ID: 25079939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.